NDC 44567-235 – Ceftazidime
Ceftazidime 1 g/1 · Injection, Powder, For Solution · Intramuscular, Intravenous
Product NDC44567-235
Product details
- Brand name
- Ceftazidime
- Generic name
- Ceftazidime
- Labeler
- WG Critical Care, LLC
- Dosage form
- Injection, Powder, For Solution
- Route
- Intramuscular, Intravenous
- Marketing category
- ANDA · ANDA062640
- Marketed since
- January 31, 2013
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cephalosporin Antibacterial
Active ingredients
- Ceftazidime 1 g/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 44567-235-25 | 25 VIAL in 1 CARTON (44567-235-25) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL | Jan 31, 2013 |
Other Ceftazidime products
- 25021-127 Ceftazidime 1 g/1 · Injection, Powder, For Solution · Sagent Pharmaceuticals
- 25021-128 Ceftazidime 2 g/1 · Injection, Powder, For Solution · Sagent Pharmaceuticals
- 25021-129 Ceftazidime 6 g/30mL · Injection, Powder, For Solution · Sagent Pharmaceuticals
- 44567-236 Ceftazidime 2 g/1 · Injection, Powder, For Solution · WG Critical Care, LLC
- 44567-237 Ceftazidime 6 g/1 · Injection, Powder, For Solution · WG Critical Care, LLC